ALISHA FULLER: Open Payments
NPI 1083616544 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 60 payments from 13 companies in 2025. Trend: 2023 $1,573 · 2024 $1,899 · 2025 $1,400
Food & beverage: $1,400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $323 |
| AstraZeneca Pharmaceuticals LP | 14 | $292 |
| PFIZER INC. | 9 | $210 |
| ABBVIE INC. | 14 | $205 |
| Lilly USA, LLC | 5 | $126 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $26 |
Products named: Ozempic, UBRELVY, BREZTRI, Wegovy, PREVNAR 20, FARXIGA, JARDIANCE, ELIQUIS.
Industry payments across NY — which companies pay providers there.
